Annual CFF
-$213.00 K
-$152.72 M-100.14%
December 31, 2022
Summary
- As of February 10, 2025, DBTX annual cash flow from financing activities is -$213.00 thousand, with the most recent change of -$152.72 million (-100.14%) on December 31, 2022.
- During the last 3 years, DBTX annual CFF has fallen by -$208.00 thousand (-4160.00%).
Performance
DBTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$206.00 K
+$9000.00+4.57%
June 30, 2023
Summary
- As of February 10, 2025, DBTX quarterly cash flow from financing activities is $206.00 thousand, with the most recent change of +$9000.00 (+4.57%) on June 30, 2023.
- Over the past year, DBTX quarterly CFF has increased by +$258.00 thousand (+496.15%).
Performance
DBTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$294.00 K
+$258.00 K+716.67%
June 30, 2023
Summary
- As of February 10, 2025, DBTX TTM cash flow from financing activities is $294.00 thousand, with the most recent change of +$258.00 thousand (+716.67%) on June 30, 2023.
- Over the past year, DBTX TTM CFF has increased by +$196.00 thousand (+200.00%).
Performance
DBTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DBTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.1% | +496.1% | +200.0% |
| 3 y3 years | -4160.0% | +100.0% | +100.0% |
| 5 y5 years | -100.4% | - | - |
DBTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.1% | at low | at high | -126.7% | -99.8% | -334.7% |
| 5 y | 5-year | -100.1% | at low | -99.9% | -507.8% | -99.9% | -334.7% |
| alltime | all time | -100.1% | at low | -99.9% | -507.8% | -99.9% | -334.7% |
Decibel Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $206.00 K(+4.6%) | $294.00 K(+716.7%) |
| Mar 2023 | - | $197.00 K(-458.2%) | $36.00 K(-116.9%) |
| Dec 2022 | -$213.00 K(-100.1%) | -$55.00 K(+1.9%) | -$213.00 K(+2942.9%) |
| Sep 2022 | - | -$54.00 K(+3.8%) | -$7000.00(-107.1%) |
| Jun 2022 | - | -$52.00 K(0.0%) | $98.00 K(-114.2%) |
| Mar 2022 | - | -$52.00 K(-134.4%) | -$690.00 K(-100.5%) |
| Dec 2021 | $152.51 M | $151.00 K(+196.1%) | $152.51 M(-26.2%) |
| Sep 2021 | - | $51.00 K(-106.1%) | $206.75 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$840.00 K(-100.5%) | $207.16 M(-0.4%) |
| Mar 2021 | - | $153.15 M(+181.6%) | $208.00 M(+279.2%) |
| Dec 2020 | $54.85 M(<-9900.0%) | $54.39 M(>+9900.0%) | $54.85 M(>+9900.0%) |
| Sep 2020 | - | $466.00 K(>+9900.0%) | $466.00 K(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | -$5000.00(-100.0%) | - | - |
| Dec 2018 | $55.06 M | - | - |
FAQ
- What is Decibel Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Decibel Therapeutics?
- What is Decibel Therapeutics annual CFF year-on-year change?
- What is Decibel Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly CFF year-on-year change?
- What is Decibel Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Decibel Therapeutics?
- What is Decibel Therapeutics TTM CFF year-on-year change?
What is Decibel Therapeutics annual cash flow from financing activities?
The current annual CFF of DBTX is -$213.00 K
What is the all time high annual CFF for Decibel Therapeutics?
Decibel Therapeutics all-time high annual cash flow from financing activities is $152.51 M
What is Decibel Therapeutics annual CFF year-on-year change?
Over the past year, DBTX annual cash flow from financing activities has changed by -$152.72 M (-100.14%)
What is Decibel Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DBTX is $206.00 K
What is the all time high quarterly CFF for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly cash flow from financing activities is $153.15 M
What is Decibel Therapeutics quarterly CFF year-on-year change?
Over the past year, DBTX quarterly cash flow from financing activities has changed by +$258.00 K (+496.15%)
What is Decibel Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DBTX is $294.00 K
What is the all time high TTM CFF for Decibel Therapeutics?
Decibel Therapeutics all-time high TTM cash flow from financing activities is $208.00 M
What is Decibel Therapeutics TTM CFF year-on-year change?
Over the past year, DBTX TTM cash flow from financing activities has changed by +$196.00 K (+200.00%)